Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UFP Technologies, Inc. - Common Stock (NQ:UFPT)

284.13 -10.71 (-3.63%)
Delayed Quote Updated: 3:02 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UFP Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
2 Reasons to avoid UFPT and 1 stock to buy instead
The past six months have been a windfall for UFP Technologies’s shareholders. The company’s stock price has jumped 41.9%, hitting $289.13 per share. This was... 
Via StockStory
Topics Supply Chain
News headline image
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how drug development input... 
Via StockStory
News headline image
3 Russell 2000 Stocks That Concern Us
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta... 
Via StockStory
News headline image
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares ↗
Feldmann reduced her direct stake by 18%. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds ↗
UFP Technologies (NASDAQ:UFPT) outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving... 
Via MarketBeat
Topics Supply Chain
News headline image
2 Profitable Stocks with Exciting Potential and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
From UFP Technologies, Inc.
Via Business Wire
News headline image
UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript ↗
Record $2.92 adjusted EPS and 15.1% net sales growth highlight strong MedTech momentum. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies delivered a calendar second quarter marked by strong, broad-based growth across its MedTech platform, which exceeded Wall Street’s revenue a... 
Via StockStory
Topics Earnings
News headline image
Why UFP Technologies Stock Is Skyrocketing Today ↗
UFP Technologies easily surpassed Wall Street's expectations and continued to deliver double-digit sales growth. 
Via The Motley Fool
News headline image
UFP Technologies Q2 Earnings Call Highlights ↗
UFP Technologies (NASDAQ:UFPT) reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per... 
Via MarketBeat
Topics Earnings
News headline image
Why Is UFP Technologies (UFPT) Stock Soaring Today
What Happened? Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 18.5% in the morning session after the company reported impressive se... 
Via StockStory
News headline image
UFP Technologies Reports Q2 2026 Results: Full Earnings Call Transcript ↗
UFP Technologies (NASDAQ:UFPT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
UFP Technologies’s (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on y... 
Via StockStory
News headline image
UFP Technologies Announces Record Q2 Results
From UFP Technologies, Inc.
Via Business Wire
News headline image
Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow
Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting results this Monday after market hours. Here’s what you need to know. UFP Technolog... 
Via StockStory
News headline image
UFP Technologies to Report Second Quarter 2026 Financial Results on August 3, 2026
From UFP Technologies, Inc.
Via Business Wire
News headline image
3 of Wall Street’s Favorite Stocks with Warning Signs
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying ↗
As small caps outpace the S&P 500 in 2026's rotation, UFP Technologies, Willdan Group, and NWPX Infrastructure show earnings and growth catalysts worth watching this year. 
Via MarketBeat
Topics Earnings Stocks
News headline image
2 Reasons UFPT is Risky and 1 Stock to Buy Instead
Over the past six months, UFP Technologies’s shares (currently trading at $244.72) have posted a disappointing 8.2% loss, well below the S&P 500’s 7.7% gain.... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
3 Hyped Up Stocks with Questionable Fundamentals
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements... 
Via StockStory
News headline image
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 26th Annual New Ideas Summer Conference
From UFP Technologies, Inc.
Via Business Wire
News headline image
UFP Technologies Director Sells $287,000 After Option Exercise as Shares Stay Flat ↗
This medical device supplier, known for custom healthcare components, reported a notable insider sale amid ongoing sector diversification. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not... 
Via StockStory
Topics Economy
News headline image
Q1 Rundown: UFP Technologies (NASDAQ:UFPT) Vs Other Drug Development Inputs & Services Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including UFP Technologies (NASDAQ:UFPT)... 
Via StockStory
News headline image
3 Russell 2000 Stocks with Warning Signs
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
From UFP Technologies, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.